Email Alert RSS
Volume 14 Issue 6
Nov.  2023
Turn off MathJax
Article Contents
Abstract
References
Related Articles
WANG Yongxuan, LI Mei, ZHANG Zhenlin, XIA Weibo. Interpretation on the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1203-1207. DOI: 10.12290/xhyxzz.2023-0364
Citation: WANG Yongxuan, LI Mei, ZHANG Zhenlin, XIA Weibo. Interpretation on the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1203-1207. DOI: 10.12290/xhyxzz.2023-0364
shu

Interpretation on the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022)

  • 1.

    Department of Endocrinology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, Fujian 365000, China

  • 2.

    Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Endocrinology National Commission of Health, Beijing 100730, China

  • 3.

    Department of Osteoporosis and Bone Disease, the Sixth People's Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Shanghai 200233, China

Funds: 

National Key R&D Program of China 2021YFC2501700

National High Level Hospital Clinical Research Funding 2022-PUMCH-D-006

More Information
  • Corresponding author:

    XIA Weibo, E-mail: xiaweibo8301@163.com

  • Received Date: August 06, 2023
  • Accepted Date: August 06, 2023
  • Available Online: September 20, 2023
  • Issue Publish Date: November 29, 2023
    Graphical Abstract
    • Abstract
  • In December 2022, the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022) were released. The guidelines have updated the latest epidemiological data of osteoporosis in China and given recommendations for the diagnosis and treatment of osteoporosis by combining evidence-based medical testimony and clinical practice in this field. This article interprets the key points of the guidelines to help healthcare workers better understand and follow the guidelines.
    • FullText(HTML)
    • References (17)
  • [1]
    Wang O, Hu Y, Gong S, et al. A survey of outcomes and management of patients post fragility fractures in China[J]. Osteoporos Int, 2015, 26: 2631-2640. DOI: 10.1007/s00198-015-3162-6
    [2]
    Hu J, Zheng W, Zhao D, et al. Health-related quality of life in men with osteoporosis: a systematic review and meta-analysis[J]. Endocrine, 2021, 74: 270-280. DOI: 10.1007/s12020-021-02792-0
    [3]
    Wang L, Yu W, Yin X, et al. Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study[J]. JAMA Netw Open, 2021, 4: e2121106. DOI: 10.1001/jamanetworkopen.2021.21106
    [4]
    中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2022)[J]. 中华骨质疏松和骨矿盐疾病杂志, 2022, 15: 573-611. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDLS202303004.htm
    [5]
    中国疾病预防控制中心, 中华医学会骨质疏松和骨矿盐疾病分会. 中国骨质疏松症流行病学调查报告(2018)[M]. 北京: 人民卫生出版社, 2021.
    [6]
    Nayak S, Edwards DL, Saleh AA, et al. Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density[J]. Osteoporos Int, 2015, 26: 1543-1554. DOI: 10.1007/s00198-015-3025-1
    [7]
    Kanis JA, Cooper C, Rizzoli R, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women[J]. Osteoporos Int, 2019, 30: 3-44. DOI: 10.1007/s00198-018-4704-5
    [8]
    Genant HK, Wu CY, van Kuijk C, et al. Vertebral fracture assessment using a semiquantitative technique[J]. J Bone Miner Res, 1993, 8: 1137-1148. DOI: 10.1002/jbmr.5650080915
    [9]
    中华医学会骨质疏松和骨矿盐疾病分会. 骨转换生化标志物临床应用指南[J]. 中华骨质疏松和骨矿盐疾病杂志, 2021, 14: 321-336. https://www.cnki.com.cn/Article/CJFDTOTAL-GUSS202104001.htm
    [10]
    Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update[J]. Endocr Pract, 2020, 26: 1-46.
    [11]
    Wilkins Parker LR, Preuss CV. Alendronate[M]. Treasure Island (FL): StatPearls Publishing, 2023.
    [12]
    Hirota Y, Nakagawa K, Isomoto K, et al. Eldecalcitol is more effective in promoting osteogenesis than alfacalci-dol in Cyp27b1-knockout mice[J]. PLoS One, 2018, 13: e0199856. DOI: 10.1371/journal.pone.0199856
    [13]
    Food and Drug Administration. Center for drug evaluation and research[EB/OL]. (2020-11-16)[2023-08-04]. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/021318Orig1s054.pdf.
    [14]
    Li N, Cornelissen D, Silverman S, et al. An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis[J]. Pharmacoeconomics, 2021, 39: 181-209. DOI: 10.1007/s40273-020-00965-9
    [15]
    李梅, 章振林, 夏维波. 骨质疏松症药物治疗的必由之路: 长程序贯治疗[J]. 中华骨质疏松和骨矿盐疾病杂志, 2021, 14: 441-446. https://www.cnki.com.cn/Article/CJFDTOTAL-GUSS202105001.htm
    [16]
    中华医学会骨质疏松和骨矿盐疾病分会. 骨质疏松性椎体压缩性骨折诊疗与管理专家共识[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11: 425-437. https://www.cnki.com.cn/Article/CJFDTOTAL-GUSS201805002.htm
    [17]
    国务院办公厅. 国务院办公厅关于推进分级诊疗制度建设的指导意见[EB/OL]. (2015-09-08)[2023-08-04]. https://www.gov.cn/zhengce/content/2015-09/11/content_10158.htm.
    • Related Articles

  • Related Articles

    [1]JIANG Nan, TIAN Xinping, ZENG Xiaofeng. Interpretation on the 2024 Chinese Guidelines for the Diagnosis and Treatment of Rheumatoid Arthritis[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(1): 28-34. DOI: 10.12290/xhyxzz.2024-1018
    [2]ZHANG Shan, LIU Jie. Interpretation of NCCN Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1.2024) Based on the Current Diagnosis and Treatment Status of China[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1029-1037. DOI: 10.12290/xhyxzz.2024-0605
    [3]TIAN Zhuang, ZHANG Shuyang. Interpretation on Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 801-806. DOI: 10.12290/xhyxzz.2024-0292
    [4]JIN Shangyi, TIAN Xinping. Interpretation on the Chinese Guideline for the Diagnosis and Treatment of Takayasu's Arteritis (2023)[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 560-566. DOI: 10.12290/xhyxzz.2024-0209
    [5]CHEN Rong. Interpretation on the 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 514-519. DOI: 10.12290/xhyxzz.2023-0190
    [6]LIANG Yun, WU Wenming, NIE Yongzhan, CHEN Jie. Interpretation on the Chinese Guideline for Diagnosis and Treatment of Neuroendocrine Neoplasms from The China Anti-Cancer Association(2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 94-100. DOI: 10.12290/xhyxzz.2022-0607
    [7]LIU Yuan, ZHAO Lin. Update and Interpretation of 2022 National Comprehensive Cancer Network Clinical Practice Guidelines for Gastric Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 999-1004. DOI: 10.12290/xhyxzz.2022-0271
    [8]JIN Bao, DU Shunda, MAO Yilei, SANG Xinting. Interpretation on the Updated Points of Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 789-795. DOI: 10.12290/xhyxzz.2022-0274
    [9]ZHAO Weigang. Interpretation on Clinical Guidelines for Prevention and Treatment of Type 2 Diabetes Mellitus in the Elderly in China (2022 Edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 574-580. DOI: 10.12290/xhyxzz.2022-0199
    [10]WANG Lin, SONG Hongmei. Interpretation on Chinese Guidelines for the Diagnosis and Treatment of Childhood-onset Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 412-420. DOI: 10.12290/xhyxzz.2022-0018

  • Cited by

    Periodical cited type(23)

    1. 杜忠秋，戚晓阳，杨平，于江林，陈一心，张林坚，邱旭升. 脯氨酰羟化酶2抑制剂cpd17对小鼠成骨前体细胞的影响. 中国组织工程研究. 2025(02): 238-244 .
    2. 王东阳，杨巧慧，林欣潮. 绝经后女性维生素D水平与生殖特点和运动膳食情况的关系. 中国组织工程研究. 2025(05): 1021-1025 .
    3. 杨世超，宋慕格，高玉海，王龙飞，王立强，安梓栋，李亮，谢高倩，陈克明. 羊胎盘粉对青年大鼠骨质量影响. 中国骨质疏松杂志. 2025(02): 175-181 .
    4. 马丹，张亚娟，马彬斌，岳乔宁，刘建平. 衰老与骨质疏松靶基因及小分子筛选的基因组分析. 昆明医科大学学报. 2025(02): 141-150 .
    5. 丁康致，王鹏，张静，张玉飞，熊海. 血尿酸/肌酐比值、OSTA对西藏地区藏族中老年人群骨质疏松预测价值研究. 四川大学学报(医学版). 2025(01): 247-253 .
    6. 王凯韬，李志伟，金杰，王建伟. 系统性免疫炎症指数与骨质疏松症的相关性研究. 中国中医骨伤科杂志. 2024(05): 46-49 .
    7. 张天驰，李沐哲，牛园园，郭杨，王礼宁，田霖坤，王遇珩，王泉荃，马勇. 温肾通络止痛方抑制巨噬细胞衰老改善BMSC成骨分化和老年性骨质疏松模型小鼠骨丢失的研究. 南京中医药大学学报. 2024(03): 249-260 .
    8. 张岳阳，黄晶，陈国珍，李宏阳，顾卫. 黄芪健骨胶囊质量标准研究. 中国药业. 2024(10): 93-97 .
    9. 吕一人，高宠，王笑民. 坤宁健骨方治疗妇科恶性肿瘤术后骨质疏松症. 长春中医药大学学报. 2024(06): 664-668 .
    10. 彭利平，辜志昌. 仙灵骨葆胶囊联合金天格胶囊治疗原发性骨质疏松症患者的临床研究. 中国临床药理学杂志. 2024(12): 1723-1727 .
    11. 王凯韬，王建伟. 急性骨丢失与骨质疏松症的关系研究进展. 现代医药卫生. 2024(12): 2114-2117 .
    12. 牛文敏，姚小贤，戴钟元，刘郑，黄平富. 金龙蛤蚧平喘加味方对COPD稳定期合并骨质疏松患者骨密度和骨代谢生化标志物的影响. 河南中医. 2024(07): 1088-1092 .
    13. 龚美胜，李生龙，安玉芳. 从精气神探讨骨质疏松相关性认知障碍的辨治思路. 中医临床研究. 2024(14): 100-104 .
    14. 金小微，苏正，施谧，吴娇臻，林佩佩. 温州社区45岁以上中老年骨质疏松患病情况及影响因素分析. 中国医院统计. 2024(03): 203-206 .
    15. 崔洪伟，王岩，周丽芸，孙亚迪，李奕扬，申佳慧，李光，马天成，封潇添，王祺钰，董本超，李岩，杨培川，马剑雄，马信龙. 老年骨质疏松性骨折的康复研究进展. 中国骨质疏松杂志. 2024(07): 1081-1085+1092 .
    16. 刘鹏飞，连振刚，李逵蒙. 腰椎脂肪分数联合R2*值对骨质疏松症的诊断价值分析. 中国CT和MRI杂志. 2024(07): 169-171 .
    17. 周润昌，刘永祥，欧阳毓. 地奥司明联合艾瑞昔布对骨质疏松性四肢骨折患者炎症因子及骨代谢水平的影响分析. 中国处方药. 2024(07): 76-78 .
    18. 黄凯华，孙强，吴志浩，王贯通，刘衡. 绝经后骨质疏松患者口服阿仑膦酸钠6个月后分别序贯地舒单抗、唑来膦酸的治疗效果对比观察. 山东医药. 2024(24): 65-68 .
    19. 文豪，肖强兵，吕浩源. 骨质疏松症名方补肾健骨汤组成及剂量数据挖掘研究. 亚太传统医药. 2024(09): 147-151 .
    20. 王迎秋，刘玮玮，李波，段智霞，刘传慧. 中老年住院患者骨质疏松症知信行现状调查及影响因素分析. 医药论坛杂志. 2024(17): 1846-1850+1855 .
    21. 马麟，刘恒，贾中杰. 2022—2023年南部县城镇社区40岁及以上中老年人骨质疏松认知水平调查. 职业卫生与病伤. 2024(05): 323-327 .
    22. 丁康致，王鹏，张静，张玉飞，熊海. 血清肌酐和血红蛋白及BMI与西藏地区藏族中老年居民骨质疏松的相关性及其预测价值分析. 西安交通大学学报(医学版). 2024(06): 1013-1019 .
    23. 李莉，申雅文，李德龙，程芳芳，于喜凤，潘琳琳，庄淑渊，董思鸿，吴娇，梁艳，臧苑彤. 脆性骨折术后患者康复自我效能感的影响因素及路径分析. 中华护理杂志. 2024(24): 3003-3008 .

    Other cited types(6)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1343) PDF downloads (885) Cited by(29)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close